Latest News

  • TECHNOLOGY

    7 Jan 2026

    Blockchain Gains Attention as Pharma Reconsiders Data Integrity

  • PARTNERSHIPS

    6 Jan 2026

    Sanofi’s $2.2B Dynavax Bet Signals a Vaccine Power Shift

  • INSIGHTS

    5 Jan 2026

    When Biomanufacturing Outgrows Its Buildings

  • RESEARCH

    19 Dec 2025

    AI Gains Ground in US Drug Fermentation

FDA PreCheck Raises the Stakes for Early Manufacturing

FDA PreCheck graphic symbolizing early regulatory review of pharmaceutical manufacturing.

REGULATORY

18 Dec 2025

FDA PreCheck pushes pharmaceutical and biologics manufacturers to align manufacturing earlier, aiming to cut approval delays and strengthen US production resilience

Stainless steel bioreactors in pharmaceutical fermentation facility

INNOVATION

14 Nov 2025

Microbes Take the Wheel in U.S. Drug Making

Fermentation is reshaping how U.S. drugs are made, cutting costs and adding resilience

Automated fermentation reactors lined up in a modern pharmaceutical lab

TECHNOLOGY

12 Nov 2025

Smarter Fermentation Takes Hold in US Pharma

US pharma leans on AI to steady fermentation and push bioprocessing into a digital era

The Quiet Revolution Brewing in Biologics

INSIGHTS

10 Nov 2025

The Quiet Revolution Brewing in Biologics

Thermo Fisher and 21st Bio fuel a transatlantic fermentation surge reshaping global biologics

Exterior view of FDA offices highlighting PreCheck program for faster plant approvals.

REGULATORY

14 Aug 2025

Can the FDA’s PreCheck End Costly Drug Launch Delays?

FDA’s PreCheck pilot accelerates drug plant reviews, boosting US biologics production and cutting costly launch delays.

Esteve headquarters symbolizing the company’s CDMO expansion into the U.S. pharma market.

PARTNERSHIPS

7 Aug 2025

From Barcelona to Chicago: Esteve Targets U.S. Drugmakers

Esteve acquires Regis to bring European CDMO expertise to US soil, boosting domestic drug ingredient development and manufacturing service...

Close-up of medicine vials representing the growing U.S. biosimilar market.

MARKET TRENDS

1 Aug 2025

The Biosimilar Boom That’s Rewriting U.S. Pharma

US payers drive biosimilar boom, pressuring fermentation drug makers to cut costs and boost domestic capacity.

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.